title: Feasibility and Advantages of Large Liver Hemangioma Treated with Laparoscopic Microwave Ablation.
abstract: OBJECTIVE
  To evaluate feasibility and superiority of large liver hemangioma treated with laparoscopic microwave ablation.
  
  
  METHODS
  Between March 2006 and May 2013, 47 patients with liver hemangioma (5-10 cm) were surgically treated in our department, and were randomly divided into three groups, laparoscopic microwave ablation group (treatment group), traditional opening group, and laparoscopic resection group. Three groups were compared in respect of postoperative ambulation time, gastrointestinal function recovery time, postoperative liver function recovery time, intraoperative blood loss, postoperative hospital stay, using SPSS13.0 software and analysis of variance, P < 0.05 indicates significant, then adopting Student-Newman-Keuls method to compare mean value of every two groups. And the treatment group of patients were tracked and reviewed.
  
  
  RESULTS
  With regard to above aspects, treatment group and two control groups were compared, P < 0.05 was considered statistically significant, then the result of S-N-K method showed that the treatment group was far better than the control group in the above four areas, however compared with traditional opening group laparoscopic resection group did not demonstrate any superiority. Tracking the patients of treatment group proved no recurrence, and one case's CT films before and after surgery were compared, further confirming the feasibility of microwave ablation.
  
  
  CONCLUSIONS
  To large hepatic hemangioma, laparoscopic microwave ablation in respect of intraoperative injury, postoperative recovery and costs is superior to other methods, and the treatment effect is certain, it's feasible and worthy of promotion.
authors.forename: Ling
authors.initials: L
authors.lastname: Liu
authors.forename: Nianfeng
authors.initials: N
authors.lastname: Li
mesh_terms: D055011:Ablation Techniques / Q000009:adverse effects / Q000379:methods; D000328:Adult; D016063:Blood Loss, Surgical / Q000706:statistics & numerical data; D002681:China; D005240:Feasibility Studies; D005260:Female; D006391:Hemangioma / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D007902:Length of Stay; D008113:Liver Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D008297:Male; D008872:Microwaves / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology; D020127:Recovery of Function; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D047368:Tumor Burden